Fiche société
Impax Laboratories, LLC
Traitements, essais et publications liés.
Traitements3programmes
Essais1liés
Publications6liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| IPX066This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease. | Parkinson | Phase 3 | À vérifier | United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine | À vérifier |
| IR CD-LDThis is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease. | Parkinson | Phase 3 | À vérifier | United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine | À vérifier |
| IPX066This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease. | Parkinson | Phase 3 | À vérifier | United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IPX066 | Parkinson | Phase 3 | NCT00974974 | A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). | COMPLETED |
Publications
6| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| IR CD-LD | Duration of "Good On" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®). | Parkinsonism & related disorders | ||
| IPX066 | Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. | Parkinsonism & related disorders | ||
| IR CD-LD | How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson's disease. | Clinical parkinsonism & related disorders | ||
| IR CD-LD | Efficacy and safety of IPX203 in Parkinson's patients: a systematic review and meta-analysis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | ||
| IPX066 | Plant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review. | Chemistry & biodiversity | ||
| IPX066 | Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America. | Frontiers in pharmacology |